Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug ...
Forbes: Lupin Pharmaceuticals Just Recalled Two Birth Control Pills - Did It Affect The Stock?
Lupin Pharmaceuticals has recalled two batches of its Tydemy birth control pills after reporting defects The company’s earnings beat reported higher profits and revenues Lupin’s share price rose 4% at ...
Lupin Pharmaceuticals Just Recalled Two Birth Control Pills - Did It Affect The Stock?
Yahoo Finance: Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Business Standard: Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets
The U.S. FDA has approved Lupin's Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets as bioequivalent to Xigduo XR for the indications in the approved labeling.
Business Standard: Lupin gets USFDA nod for Dapagliflozin and Metformin ER tablets
Lupin said that it has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Dapagliflozin and Metformin Hydrochloride extended-release ...
MarketWatch: Lupin Announces the Approval of Dapagliflozin Tablets in the United States
The U.S. FDA has approved Lupin's Dapagliflozin Tablets, 5 mg and 10 mg, as bioequivalent to Farxiga (R) for the indications in the approved labeling.
Mint on MSN: Lupin shares to be in focus on Thursday as USFDA approves dapagliflozin and metformin tablets